Farms.com Home   News

Porcine Circovirus Webinar Provides Timely Updates, SHIC Says

Porcine circovirus (PCV) presents a significant swine disease challenge, says the Swine Health Information Center (SHIC). That's why it is included in SHIC’s 2024 Plan of Work as a priority pathogen.

SHIC, along with the American Association of Swine Veterinarians, recently held a webinar focused on emerging trends of porcine circovirus. Expert presenters provided the latest information on porcine circovirus including domestic and global distribution, new research updates, diagnostic trends, sample types submitted for surveillance, interpretation of test results and practitioner perspectives for disease management strategies.  

Tanja Opriessnig of Iowa State University provided a general disease overview including domestic and global distribution, recent research outcomes and an update on PCV4. She said although PCVs were first identified approximately 27 years ago, an improved understanding of circoviruses and their impact on swine health has continued to evolve over time.  

"PCV2 has been a significant health challenge for global pig producers for many decades. Dr. Opriessnig said PCV2-specific vaccines have worked remarkably well to prevent viral health impacts since global introduction in 2006. Modern PCV2 vaccines provide cross-protection against currently known PCV2 genotypes and are among the most widely used vaccine in growing pigs. Dr. Opriessnig shared evidence of the global distribution of PCV3 as well as the recent identification of PCV4 in Asia and Spain, saying a more field-based approach is needed for prevention, preparedness, and response to emerging PCVs. Dr. Opriessnig remarked that initial evidence shows that PCV3 vaccines are helpful for control and that monitoring for emerging strains, including porcine circovirus-like viruses, is ongoing," SHIC reports in its latest newsletter.

Darin Madson of the Iowa State University Veterinary Diagnostic Lab (ISU VDL) said PCV2 is a globally distributed and ubiquitous virus with very few negative swine herds in the US. PCV2 ranks as one of the top three infectious agents in the swine industry. Madson explained that infection generally occurs after waning of maternal antibodies in pigs 7- to 15-weeks of age. Transmission of PCV2 is possible both horizontally (pig to pig) and vertically (dam to offspring) through nasal-oral and fecal-oral routes. He pointed out a major route of transmission occurs through virus secreted and/or excreted in urine, ocular discharge, nasal discharge, saliva and feces. Fomites capable of transmission include needles, insects, and rodents. Aerosol transmission of PCV2 is possible as the virus has been detected in exhaust air and dust outside barns; however, infectivity is unknown. 

During his presentation, Madson shared an AASV Board-approved porcine circovirus position statement to aid in accurate diagnosis of PCV.  

PCVAD can be subclinical or include one or more of the following clinical manifestations concurrently:

Click here to see more...

Trending Video

Unveiling a Breakthrough Genetic Solution for Future-Proof, Sustainable Pork Production

Video: Unveiling a Breakthrough Genetic Solution for Future-Proof, Sustainable Pork Production


Marcel Huijsmans, Global Marketing Director at Topigs Norsvin tells us about their new genetic solution R3silience that offers a solid alternative to how the industry can approach disease management.

R3silience delivers scientifically proven, naturally resilient pigs that thrive under disease pressure, enabling more predictable, sustainable production by reducing losses and sustaining growth under disease challenge.

R3silience pigs deliver higher survival, stronger overall performance, and healthier herds - reducing wean-to-finish mortality by up to 6 percentage points during multifactorial PRRS outbreak*.

R3silience pigs not only show higher survival, but also deliver superior growth, improving daily weight gain by up to 0.04lbs. per day under multifactorial PRRS outbreak.*

Pigs with enhanced resilience to both viral and bacterial diseases require fewer health interventions and up to 8% less antibiotic treatments from wean-to-finish*, supporting better animal welfare.

For more information visit https://topigsnorsvin.com/products/r3...